| scholarly article | Q13442814 |
| P50 | author | Carl F. Nathan | Q1037710 |
| P2093 | author name string | North RJ | |
| MacMicking JD | |||
| Shah SK | |||
| Mudgett JS | |||
| LaCourse R | |||
| P2860 | cites work | Lipoarabinomannan, a possible virulence factor involved in persistence of Mycobacterium tuberculosis within macrophages | Q24644376 |
| Protective role of γ/δ T cells and α/β T cells in tuberculosis | Q57599016 | ||
| A direct effect of glucocorticoid hormones on the ability of human and murine macrophages to control the growth of M. tuberculosis | Q70370072 | ||
| Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase | Q71694221 | ||
| Multiple defects of immune cell function in mice with disrupted interferon-gamma genes | Q28267397 | ||
| Natural resistance to infection with intracellular parasites: isolation of a candidate for Bcg | Q28269092 | ||
| Automatable radiometric detection of growth of Mycobacterium tuberculosis in selective media | Q28319361 | ||
| Effects of nitric oxide synthase inhibitors on murine infection with Mycobacterium tuberculosis | Q28367637 | ||
| The Ity/Lsh/Bcg locus: natural resistance to infection with intracellular parasites is abrogated by disruption of the Nramp1 gene | Q28589797 | ||
| Nitric oxide and macrophage function | Q29615327 | ||
| An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection | Q29616521 | ||
| Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages | Q29617356 | ||
| Simplified mammalian DNA isolation procedure | Q29618648 | ||
| Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice | Q29622922 | ||
| Interaction with extracellular matrix proteins influences Lsh/Ity/Bcg (candidate Nramp) gene regulation of macrophage priming/activation for tumour necrosis factor-alpha and nitrite release. | Q30194385 | ||
| Molecular mechanisms of dexamethasone inhibition of nitric oxide synthase expression in interleukin 1 beta-stimulated mesangial cells: evidence for the involvement of transcriptional and posttranscriptional regulation | Q33614403 | ||
| Genetic and redox determinants of nitric oxide cytotoxicity in a Salmonella typhimurium model | Q34123367 | ||
| Mechanisms of recrudescence of Mycobacterium bovis BCG infection in mice | Q35096828 | ||
| Roles of nitric oxide in inducible resistance of Escherichia coli to activated murine macrophages | Q35390580 | ||
| Growth of Mycobacterium tuberculosis in BCG-resistant and -susceptible mice: establishment of latency and reactivation | Q35417336 | ||
| The influence of corticotrophin and certain corticosteroids on populations of Mycobacterium tuberculosis in tissues of mice | Q36152649 | ||
| Microbial persistence. I. The capacity of tubercle bacilli to survive sterilization in mouse tissues | Q36268025 | ||
| Mice that lack the interferon-gamma receptor have profoundly altered responses to infection with Bacillus Calmette-Guérin and subsequent challenge with lipopolysaccharide. | Q36362408 | ||
| Nitric oxide potentiates hydrogen peroxide-induced killing of Escherichia coli. | Q36365394 | ||
| Evidence inconsistent with a role for the Bcg gene (Nramp1) in resistance of mice to infection with virulent Mycobacterium tuberculosis | Q36365796 | ||
| Reactivation of latent leishmaniasis by inhibition of inducible nitric oxide synthase | Q36366480 | ||
| Inducible nitric oxide synthase in pulmonary alveolar macrophages from patients with tuberculosis | Q36366661 | ||
| Mechanisms involved in mycobacterial growth inhibition by gamma interferon-activated bone marrow macrophages: role of reactive nitrogen intermediates | Q36968357 | ||
| Major histocompatibility complex class I-restricted T cells are required for resistance to Mycobacterium tuberculosis infection | Q37347705 | ||
| Cloning and characterization of inducible nitric oxide synthase from mouse macrophages | Q38329463 | ||
| Anti-inflammatory actions of steroids: molecular mechanisms | Q40386939 | ||
| Carboxyl terminus of inducible nitric oxide synthase. Contribution to NADPH binding and enzymatic activity | Q41429540 | ||
| Glucocorticoids inhibit the induction of nitric oxide synthase in macrophages | Q41714852 | ||
| Mycobacterial virulence. Virulent strains of Mycobacteria tuberculosis have faster in vivo doubling times and are better equipped to resist growth-inhibiting functions of macrophages in the presence and absence of specific immunity | Q41780161 | ||
| Apoptosis, but not necrosis, of infected monocytes is coupled with killing of intracellular bacillus Calmette-Guérin | Q41867941 | ||
| L-N6-(1-iminoethyl)lysine: a selective inhibitor of inducible nitric oxide synthase. | Q42275426 | ||
| L-N6-(1-iminoethyl)-lysine potently inhibits inducible nitric oxide synthase and is superior to NG-monomethyl-arginine in vitro and in vivo. | Q43926524 | ||
| The Nramp1 antimicrobial resistance gene segregates independently of resistance to virulent Mycobacterium tuberculosis | Q44151130 | ||
| Haplotype mapping and sequence analysis of the mouse Nramp gene predict susceptibility to infection with intracellular parasites. | Q44615539 | ||
| Altered immune responses in mice lacking inducible nitric oxide synthase | Q44662136 | ||
| Interferon-gamma-treated murine macrophages inhibit growth of tubercle bacilli via the generation of reactive nitrogen intermediates | Q44828688 | ||
| Tumor necrosis factor and granulocyte macrophage-colony stimulating factor stimulate human macrophages to restrict growth of virulent Mycobacterium avium and to kill avirulent M. avium: killing effector mechanism depends on the generation of reactiv | Q44904847 | ||
| Global epidemiology of tuberculosis. Morbidity and mortality of a worldwide epidemic | Q46228076 | ||
| Homocysteine antagonism of nitric oxide-related cytostasis in Salmonella typhimurium | Q50139335 | ||
| The kinetics of emergence and loss of mediator T lymphocytes acquired in response to infection with Mycobacterium tuberculosis. | Q52135468 | ||
| Requirement for transcription factor IRF-1 in NO synthase induction in macrophages. | Q52507356 | ||
| Nitrosative stress: activation of the transcription factor OxyR. | Q54580956 | ||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | tuberculosis | Q12204 |
| P304 | page(s) | 5243-8 | |
| P577 | publication date | 1997-05-13 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | Identification of nitric oxide synthase as a protective locus against tuberculosis | |
| P478 | volume | 94 |
| Q24523233 | 1,25-Dihydroxyvitamin D3 induces nitric oxide synthase and suppresses growth of Mycobacterium tuberculosis in a human macrophage-like cell line |
| Q42215986 | 19F NMR as a probe of ligand interactions with the iNOS binding site of SPRY domain-containing SOCS box protein 2. |
| Q34084410 | 1alpha,25-Dihydroxyvitamin D3-induced monocyte antimycobacterial activity is regulated by phosphatidylinositol 3-kinase and mediated by the NADPH-dependent phagocyte oxidase |
| Q46037070 | 5'-Adenosinephosphosulphate reductase (CysH) protects Mycobacterium tuberculosis against free radicals during chronic infection phase in mice. |
| Q64082342 | : Bacterial Fitness within the Host Macrophage |
| Q35689078 | A Mycobacterium marinum mel2 mutant is defective for growth in macrophages that produce reactive oxygen and reactive nitrogen species |
| Q36845283 | A Mycobacterium tuberculosis Rpf double-knockout strain exhibits profound defects in reactivation from chronic tuberculosis and innate immunity phenotypes |
| Q44203454 | A combined DNA vaccine enhances protective immunity against Mycobacterium tuberculosis and Brucella abortus in the presence of an IL-12 expression vector |
| Q28487591 | A cooperative oxygen-binding hemoglobin from Mycobacterium tuberculosis |
| Q33738007 | A dichotomous role for nitric oxide during acute Toxoplasma gondii infection in mice |
| Q37211779 | A journey in science: promise, purpose, privilege |
| Q33606785 | A mAb recognizing a surface antigen of Mycobacterium tuberculosis enhances host survival |
| Q24650149 | A membrane protein preserves intrabacterial pH in intraphagosomal Mycobacterium tuberculosis |
| Q53746161 | A multi-stress model for high throughput screening against non-replicating Mycobacterium tuberculosis. |
| Q36380939 | A novel antioxidant gene from Mycobacterium tuberculosis |
| Q30833352 | A peptide permease mutant of Mycobacterium bovis BCG resistant to the toxic peptides glutathione and S-nitrosoglutathione |
| Q56452784 | A polymorphism in the inducible nitric oxide synthase gene is associated with tuberculosis |
| Q92351689 | A role for S-nitrosylation of the SUMO-conjugating enzyme SCE1 in plant immunity |
| Q39133864 | A role for interleukin-17A in modulating intracellular survival of Mycobacterium bovis bacillus Calmette-Guérin in murine macrophages |
| Q33753828 | A tumor necrosis factor mimetic peptide activates a murine macrophage cell line to inhibit mycobacterial growth in a nitric oxide-dependent fashion |
| Q42183991 | Abrogating TNF-α expression prevents bystander destruction of normal tissues during iNOS-mediated elimination of intraocular tumors |
| Q37494077 | Acid resistance in Mycobacterium tuberculosis |
| Q34172138 | Activation of toll-like receptors by microbial lipoproteins |
| Q87913417 | Activity of cyclooxygenase-2 and nitric oxide in milk leucocytes following intramammary inoculation of a bio-response modifier during bovine Staphylococcus aureus subclinical mastitis |
| Q28235685 | Acylation determines the toll-like receptor (TLR)-dependent positive versus TLR2-, mannose receptor-, and SIGNR1-independent negative regulation of pro-inflammatory cytokines by mycobacterial lipomannan |
| Q37648714 | Adjusting to a new home: Mycobacterium tuberculosis gene expression in response to an intracellular lifestyle |
| Q58827811 | Adjuvant modulation of the cytokine balance in Mycobacterium tuberculosis subunit vaccines; immunity, pathology and protection |
| Q36575459 | Aerosolized gamma interferon (IFN-gamma) induces expression of the genes encoding the IFN-gamma-inducible 10-kilodalton protein but not inducible nitric oxide synthase in the lung during tuberculosis. |
| Q28486763 | Alkyl hydroperoxide reductase subunit C (AhpC) protects bacterial and human cells against reactive nitrogen intermediates |
| Q41835746 | Alphabeta T cell receptor-positive cells and interferon-gamma, but not inducible nitric oxide synthase, are critical for granuloma necrosis in a mouse model of mycobacteria-induced pulmonary immunopathology |
| Q52934669 | Alternative activation deprives macrophages of a coordinated defense program to Mycobacterium tuberculosis. |
| Q41139105 | An ensemble-guided approach identifies ClpP as a major regulator of transcript levels in nitric oxide-stressed Escherichia coli |
| Q44064936 | Analysis of nitric oxide synthase and nitrotyrosine expression in human pulmonary tuberculosis |
| Q28487534 | Analysis of the phthiocerol dimycocerosate locus of Mycobacterium tuberculosis. Evidence that this lipid is involved in the cell wall permeability barrier |
| Q38087272 | Antigen-specific CD8(+) T cells and protective immunity to tuberculosis |
| Q24799192 | Antitubercular therapy decreases nitric oxide production in HIV/TB coinfected patients |
| Q24550676 | Antiviral actions of interferons |
| Q41194033 | Arginase 1 activity worsens lung-protective immunity against Streptococcus pneumoniae infection |
| Q34083760 | Arginine usage in mycobacteria-infected macrophages depends on autocrine-paracrine cytokine signaling |
| Q38044374 | Arginine-based inhibitors of nitric oxide synthase: therapeutic potential and challenges |
| Q34001537 | Attenuated host resistance against Mycobacterium bovis BCG infection in mice lacking osteopontin |
| Q42540536 | Autocrine IL-10 induces hallmarks of alternative activation in macrophages and suppresses antituberculosis effector mechanisms without compromising T cell immunity |
| Q39096513 | Autophagy activation by interferon-γ via the p38 mitogen-activated protein kinase signalling pathway is involved in macrophage bactericidal activity |
| Q26778726 | Bacterial Proteasomes |
| Q28073414 | Bacterial Proteasomes: Mechanistic and Functional Insights |
| Q40262562 | Badger macrophages fail to produce nitric oxide, a key anti-mycobacterial effector molecule |
| Q37755037 | Bench-to-bedside review: the role of nitric oxide in sepsis |
| Q38140574 | Beneficial role of vitamin D3 in the prevention of certain respiratory diseases |
| Q92651130 | Biology and Biochemistry of Bacterial Proteasomes |
| Q64120074 | Biphasic Dynamics of Macrophage Immunometabolism during Infection |
| Q41472871 | Blocking the mitogen activated protein kinase-p38 pathway is associated with increase expression of nitric oxide synthase and higher production of nitric oxide by bovine macrophages infected with Mycobacterium avium subsp paratuberculosis |
| Q37582812 | Both inducible nitric oxide synthase and NADPH oxidase contribute to the control of virulent phase I Coxiella burnetii infections |
| Q39544582 | Burkholderia pseudomallei interferes with inducible nitric oxide synthase (iNOS) production: a possible mechanism of evading macrophage killing |
| Q80576892 | CD4 T cells producing IFN-gamma in the lungs of mice challenged with mycobacteria express a CD27-negative phenotype |
| Q33762255 | CD4 T cells promote rather than control tuberculosis in the absence of PD-1-mediated inhibition |
| Q37712789 | CD4+ T Cells: guardians of the phagosome |
| Q79361605 | CD40, but not CD40L, is required for the optimal priming of T cells and control of aerosol M. tuberculosis infection |
| Q95362569 | Cell death at the cross roads of host-pathogen interaction in Mycobacterium tuberculosis infection |
| Q34287676 | Cell-autonomous effector mechanisms against mycobacterium tuberculosis |
| Q34982062 | Cell-mediated immune responses in tuberculosis |
| Q35996521 | Cellular and humoral mechanisms involved in the control of tuberculosis |
| Q64109860 | Characterisation of genes differentially expressed in macrophages by virulent and attenuated Mycobacterium tuberculosis through RNA-Seq analysis |
| Q28487287 | Characterization of Mce4A protein of Mycobacterium tuberculosis: role in invasion and survival |
| Q28486680 | Characterization of the proteasome accessory factor (paf) operon in Mycobacterium tuberculosis |
| Q39571812 | Clearance of Shigella flexneri infection occurs through a nitric oxide-independent mechanism |
| Q42212641 | Clinical Mycobacterium tuberculosis isolates from the population of Łódź, Poland stimulated macrophages to the lower production of IL-12 and NO when compared to the virulent H37Rv strain |
| Q47247699 | Clinical trials in the genomic era: effects of protective genotypes on sample size and duration of trial |
| Q44480446 | Cocaine increases inducible nitric oxide synthase expression in rats: effects of acute and binge administration |
| Q34330689 | Comparative analysis of mycobacterial truncated hemoglobin promoters and the groEL2 promoter in free-living and intracellular mycobacteria |
| Q74129598 | Comparative roles of free fatty acids with reactive nitrogen intermediates and reactive oxygen intermediates in expression of the anti-microbial activity of macrophages against Mycobacterium tuberculosis |
| Q92880054 | Comparing the Metabolic Capabilities of Bacteria in the Mycobacterium tuberculosis Complex |
| Q34290885 | Comparison of BCG prime-DNA booster and rBCG regimens for protection against tuberculosis |
| Q43459073 | Confrontation between intracellular bacteria and the immune system. |
| Q28284077 | Constitutive and adaptive detoxification of nitric oxide in Escherichia coli. Role of nitric-oxide dioxygenase in the protection of aconitase |
| Q82177222 | Construction and evaluation of a multistage Mycobacterium tuberculosis subunit vaccine candidate Mtb10.4-HspX |
| Q38293610 | Containment of aerogenic Mycobacterium tuberculosis infection in mice does not require MyD88 adaptor function for TLR2, -4 and -9. |
| Q35083799 | Contribution of transmembrane tumor necrosis factor to host defense against Mycobacterium bovis bacillus Calmette-guerin and Mycobacterium tuberculosis infections. |
| Q54411685 | Control of Mycobacterium fortuitum and Mycobacterium intracellulare infections with respect to distinct granuloma formations in livers of BALB/c mice. |
| Q33463449 | Convergence of IL-1beta and VDR activation pathways in human TLR2/1-induced antimicrobial responses |
| Q37159082 | Conversion of NO2 to NO by reduced coenzyme F420 protects mycobacteria from nitrosative damage |
| Q73952727 | Correction of defective host response to Mycobacterium bovis BCG infection in TNF-deficient mice by bone marrow transplantation |
| Q43241985 | Correlates of Vaccine-Induced Protection against Mycobacterium tuberculosis Revealed in Comparative Analyses of Lymphocyte Populations |
| Q27334479 | Critical and independent role for SOCS3 in either myeloid or T cells in resistance to Mycobacterium tuberculosis |
| Q64118848 | Crucial Role of Nucleic Acid Sensing via Endosomal Toll-Like Receptors for the Defense of and |
| Q35045291 | Curcumin, the major component of food flavour turmeric, reduces mucosal injury in trinitrobenzene sulphonic acid-induced colitis |
| Q27652203 | Cysteine synthase (CysM) of Mycobacterium tuberculosis is an O-phosphoserine sulfhydrylase: evidence for an alternative cysteine biosynthesis pathway in mycobacteria |
| Q42016478 | Cytosolic phospholipase A2 enzymes are not required by mouse bone marrow-derived macrophages for the control of Mycobacterium tuberculosis in vitro |
| Q37455209 | DNA repair in Mycobacterium tuberculosis revisited |
| Q37762580 | DNA repair systems and the pathogenesis of Mycobacterium tuberculosis: varying activities at different stages of infection |
| Q37353800 | Decreased outer membrane permeability protects mycobacteria from killing by ubiquitin-derived peptides |
| Q34474594 | Defective localization of the NADPH phagocyte oxidase to Salmonella-containing phagosomes in tumor necrosis factor p55 receptor-deficient macrophages |
| Q28486752 | Deletion of the Mycobacterium tuberculosis pknH gene confers a higher bacillary load during the chronic phase of infection in BALB/c mice |
| Q36368663 | Depletion of CD4(+) T cells causes reactivation of murine persistent tuberculosis despite continued expression of interferon gamma and nitric oxide synthase 2 |
| Q28486549 | DevS, a heme-containing two-component oxygen sensor of Mycobacterium tuberculosis |
| Q35923290 | Diagnostic implications of antigen-induced gamma interferon, nitric oxide, and tumor necrosis factor alpha production by peripheral blood mononuclear cells from Mycobacterium bovis-infected cattle |
| Q34581349 | Different innate ability of I/St and A/Sn mice to combat virulent Mycobacterium tuberculosis: phenotypes expressed in lung and extrapulmonary macrophages |
| Q78140662 | Different types of pulmonary granuloma necrosis in immunocompetent vs. TNFRp55-gene-deficient mice aerogenically infected with highly virulent Mycobacterium avium |
| Q41030997 | Differential Requirements for L-Citrulline and L-Arginine during Antimycobacterial Macrophage Activity |
| Q64075197 | Differential Targeting of c-Maf, Bach-1, and Elmo-1 by microRNA-143 and microRNA-365 Promotes the Intracellular Growth of in Alternatively IL-4/IL-13 Activated Macrophages |
| Q34684829 | Differential and site specific impact of B cells in the protective immune response to Mycobacterium tuberculosis in the mouse |
| Q33787988 | Differential effects of total and partial neutralization of tumor necrosis factor on cell-mediated immunity to Mycobacterium bovis BCG infection |
| Q26849516 | Differential effects of type I and II interferons on myeloid cells and resistance to intracellular bacterial infections |
| Q44738814 | Differential pattern of cytokine expression by macrophages infected in vitro with different Mycobacterium tuberculosis genotypes |
| Q74080202 | Differential requirement for interferon-gamma to restrict the growth of or eliminate some recently identified species of nontuberculous mycobacteria in vivo |
| Q28487554 | Dihydrolipoamide acyltransferase is critical for Mycobacterium tuberculosis pathogenesis |
| Q42097645 | Direct EPR Detection of Nitric Oxide in Mice Infected with the Pathogenic Mycobacterium Mycobacterium tuberculosis |
| Q35556503 | Disruption of an M. tuberculosis membrane protein causes a magnesium-dependent cell division defect and failure to persist in mice |
| Q37716173 | Disruption of immune regulation by microbial pathogens and resulting chronic inflammation. |
| Q38095347 | Division of labor between lung dendritic cells and macrophages in the defense against pulmonary infections |
| Q37427183 | Down-modulation of lung immune responses by interleukin-10 and transforming growth factor beta (TGF-beta) and analysis of TGF-beta receptors I and II in active tuberculosis. |
| Q35020400 | Drug targets in mycobacterial sulfur metabolism |
| Q91057942 | Dynamic balance of pro- and anti-inflammatory signals controls disease and limits pathology |
| Q40282623 | Dynamic life and death interactions between Mycobacterium smegmatis and J774 macrophages |
| Q73503940 | Dynamic state of S-nitrosothiols in human plasma and whole blood |
| Q36238449 | E1 of α-ketoglutarate dehydrogenase defends Mycobacterium tuberculosis against glutamate anaplerosis and nitroxidative stress. |
| Q36951826 | ESAT-6-dependent cytosolic pattern recognition drives noncognate tuberculosis control in vivo |
| Q35802308 | Early induction of humoral and cellular immune responses during experimental Mycobacterium avium subsp. paratuberculosis infection of calves |
| Q34258958 | Effect of Mycobacterium tuberculosis-specific 10-kilodalton antigen on macrophage release of tumor necrosis factor alpha and nitric oxide |
| Q73417362 | Effect of adhesion on inducible nitric oxide synthase (iNOS) production in purified human neutrophils |
| Q39471630 | Effect of rifampin on production of inflammatory mediators in HepG2 liver epithelial cells |
| Q38745991 | Effects of Mycobacterium tuberculosis ESAT6-CFP10 Protein on Cell Viability and Production of Nitric Oxide in Alveolar Macrophages |
| Q43795076 | Effects of prostaglandin E2 and nitric oxide inhibitors on the expression of interleukin-10, interleukin-12 and MHC class-II molecules in Mycobacterium microti-infected and interferon-gamma-treated mouse peritoneal macrophages |
| Q46822732 | Efficacy of membrane TNF mediated host resistance is dependent on mycobacterial virulence |
| Q45875337 | Efficient tuberculosis treatment in mice using chemotherapy and immunotherapy with the combined DNA vaccine encoding Ag85B, MPT-64 and MPT-83. |
| Q38981524 | Emerging role of mesenchymal stem cells during tuberculosis: The fifth element in cell mediated immunity |
| Q33389187 | Enhanced and enduring protection against tuberculosis by recombinant BCG-Ag85C and its association with modulation of cytokine profile in lung |
| Q36043946 | Enhanced protection to Mycobacterium tuberculosis infection in IL-10-deficient mice is accompanied by early and enhanced Th1 responses in the lung |
| Q27749075 | Enzyme inactivation through sulfhydryl oxidation by physiologic NO-carriers |
| Q44653973 | Enzymes that Counteract Nitrosative Stress Promote Fungal Virulence |
| Q28246441 | Essential roles of S-nitrosothiols in vascular homeostasis and endotoxic shock |
| Q34113978 | Etanercept exacerbates inflammation and pathology in a rabbit model of active pulmonary tuberculosis |
| Q34183965 | Evidence inconsistent with a negative influence of T helper 2 cells on protection afforded by a dominant T helper 1 response against Mycobacterium tuberculosis lung infection in mice |
| Q27323963 | Exploitation of Mycobacterium tuberculosis reporter strains to probe the impact of vaccination at sites of infection |
| Q36890945 | Expression and characterization of recombinant interferon gamma (IFN-gamma) from the nine-banded armadillo (Dasypus novemcinctus) and its effect on Mycobacterium leprae-infected macrophages. |
| Q45999361 | Expression levels of 10 candidate genes in lung tissue of vaccinated and TB-infected cynomolgus macaques. |
| Q39729094 | Expression of PE_PGRS 62 protein in Mycobacterium smegmatis decrease mRNA expression of proinflammatory cytokines IL-1beta, IL-6 in macrophages |
| Q34467579 | Expression of Th1-mediated immunity in mouse lungs induces a Mycobacterium tuberculosis transcription pattern characteristic of nonreplicating persistence |
| Q22008706 | Expression of inducible nitric oxide synthase in human granulomas and histiocytic reactions |
| Q34005254 | Expression of the nitric oxide synthase 2 gene is not essential for early control of Mycobacterium tuberculosis in the murine lung |
| Q52665598 | Extracellular Vesicles Released from Mycobacterium tuberculosis-Infected Neutrophils Promote Macrophage Autophagy and Decrease Intracellular Mycobacterial Survival. |
| Q35805464 | Failure to recruit anti-inflammatory CD103+ dendritic cells and a diminished CD4+ Foxp3+ regulatory T cell pool in mice that display excessive lung inflammation and increased susceptibility to Mycobacterium tuberculosis |
| Q52931841 | Fas-FasL interaction modulates nitric oxide production in Trypanosoma cruzi-infected mice. |
| Q37700302 | Fatal Mycobacterium tuberculosis infection despite adaptive immune response in the absence of MyD88. |
| Q33877173 | Fatal granuloma necrosis without exacerbated mycobacterial growth in tumor necrosis factor receptor p55 gene-deficient mice intravenously infected with Mycobacterium avium |
| Q37846876 | For better or for worse: the immune response against Mycobacterium tuberculosis balances pathology and protection |
| Q37355045 | Functional Characterization of PknI-Rv2159c Interaction in Redox Homeostasis of Mycobacterium tuberculosis |
| Q34759812 | Functional heterogeneity of colony-stimulating factor-induced human monocyte-derived macrophages |
| Q35186608 | Further characterization of a highly attenuated Yersinia pestis CO92 mutant deleted for the genes encoding Braun lipoprotein and plasminogen activator protease in murine alveolar and primary human macrophages |
| Q36421483 | Game of 'Somes: Protein Destruction for Mycobacterium tuberculosis Pathogenesis |
| Q33558303 | Gamma interferon and monophosphoryl lipid A-trehalose dicorynomycolate are efficient adjuvants for Mycobacterium tuberculosis multivalent acellular vaccine |
| Q34004863 | Gamma interferon is essential for clearing Mycobacterium genavense infection |
| Q33867123 | Gamma interferon production is critical for protective immunity to infection with blood-stage Plasmodium berghei XAT but neither NO production nor NK cell activation is critical |
| Q43575463 | Gaseous nitric oxide exhibits minimal effect on skin fibroblast extracellular matrix gene expression and immune cell viability |
| Q35150399 | Gene expression profiles of bronchoalveolar cells in pulmonary TB |
| Q40807157 | Genetic background affects the expansion of macrophage subsets in the lungs of Mycobacterium tuberculosis-infected hosts. |
| Q33681241 | Glucocorticoids Suppress Antimicrobial Autophagy and Nitric Oxide Production and Facilitate Mycobacterial Survival in Macrophages |
| Q42158605 | Glyoxalase I is a novel nitric-oxide-responsive protein |
| Q33720520 | Granulysin: a lethal weapon of cytolytic T cells |
| Q92096745 | Growth hormone-mediated reprogramming of macrophage transcriptome and effector functions |
| Q40609000 | HIF-1α Is an Essential Mediator of IFN-γ-Dependent Immunity to Mycobacterium tuberculosis. |
| Q91868702 | Harnessing the Immunomodulatory Properties of Bacterial Ghosts to Boost the Anti-mycobacterial Protective Immunity |
| Q99625046 | Heme oxygenase-1 inhibition promotes IFNγ- and NOS2-mediated control of Mycobacterium tuberculosis infection |
| Q36737557 | Heme oxygenase-1-derived carbon monoxide induces the Mycobacterium tuberculosis dormancy regulon |
| Q49310880 | High Antigen Dose Is Detrimental to Post-Exposure Vaccine Protection against Tuberculosis |
| Q44248755 | Homology modeling, molecular docking and DNA binding studies of nucleotide excision repair UvrC protein from M. tuberculosis. |
| Q33831917 | Host control of Mycobacterium tuberculosis is regulated by 5-lipoxygenase-dependent lipoxin production |
| Q54540787 | Host response: Inflammation promotes TB growth. |
| Q34572120 | How can immunology contribute to the control of tuberculosis? |
| Q34430331 | Human beta casein fragment (54-59) modulates M. bovis BCG survival and basic transcription factor 3 (BTF3) expression in THP-1 cell line |
| Q93012032 | Hydrogen sulfide stimulates Mycobacterium tuberculosis respiration, growth and pathogenesis |
| Q36804177 | Hypercholesterolemia impairs immunity to tuberculosis |
| Q28476626 | Hypoxia induces an immunodominant target of tuberculosis specific T cells absent from common BCG vaccines |
| Q58461882 | IFN-γ and NO in mycobacterial disease: new jobs for old hands |
| Q39651017 | IFN-γpromotes THP-1 cell apoptosis during early infection withMycobacterium bovisby activating different apoptotic signaling |
| Q40159927 | IFNγ-producing CD4+ T lymphocytes: the double-edged swords in tuberculosis |
| Q45396453 | IL-1beta (+3954C/T) polymorphism could protect human immunodeficiency virus (HIV)-infected patients on highly active antiretroviral treatment (HAART) against lipodystrophic syndrome. |
| Q36754320 | IL-1β promotes antimicrobial immunity in macrophages by regulating TNFR signaling and caspase-3 activation |
| Q34608524 | IL-22 is mainly produced by IFNγ-secreting cells but is dispensable for host protection against Mycobacterium tuberculosis infection |
| Q78177373 | IRG1 and Inducible Nitric Oxide Synthase Act Redundantly with Other Interferon-Gamma-Induced Factors To Restrict Intracellular Replication of Legionella pneumophila. |
| Q28486518 | Identification of Mycobacterium tuberculosis counterimmune (cim) mutants in immunodeficient mice by differential screening |
| Q28487015 | Identification of a Mycobacterium tuberculosis gene that enhances mycobacterial survival in macrophages |
| Q52375535 | Identification of a Mycothiol-Dependent Nitroreductase from Mycobacterium tuberculosis. |
| Q34591872 | Identification of a chemical that inhibits the mycobacterial UvrABC complex in nucleotide excision repair |
| Q28487141 | Identification of a copper-binding metallothionein in pathogenic mycobacteria |
| Q33291875 | Identification of gene targets against dormant phase Mycobacterium tuberculosis infections |
| Q36055995 | Identification of hamster inducible nitric oxide synthase (iNOS) promoter sequences that influence basal and inducible iNOS expression |
| Q33784143 | Identification of nitric oxide synthase 2 as an innate resistance locus against ectromelia virus infection. |
| Q28487088 | Identification of substrates of the Mycobacterium tuberculosis proteasome |
| Q40656316 | Imatinib Triggers Phagolysosome Acidification and Antimicrobial Activity against Mycobacterium bovis Bacille Calmette-Guérin in Glucocorticoid-Treated Human Macrophages. |
| Q34219869 | Immune evasion by Mycobacterium tuberculosis: living with the enemy |
| Q34720248 | Immune responses to defined antigens of Mycobacterium bovis in cattle experimentally infected with Mycobacterium kansasii. |
| Q34332652 | Immune responses to intracellular bacteria. |
| Q39271619 | Immunobiology of Nitric Oxide and Regulation of Inducible Nitric Oxide Synthase |
| Q91820033 | Immunology of Mycobacterium tuberculosis Infections |
| Q35605935 | Immunology of tuberculosis and implications in vaccine development |
| Q91212060 | Immunometabolism at the interface between macrophages and pathogens |
| Q27021247 | Immunometabolism in Tuberculosis |
| Q38613635 | Immunometabolism within the tuberculosis granuloma: amino acids, hypoxia, and cellular respiration. |
| Q35447373 | Immunomodulation by vitamin D: implications for TB. |
| Q39283587 | Immunomodulatory effects of Bacillus subtilis (natto) B4 spores on murine macrophages |
| Q39517388 | Immunopathologic effects of tumor necrosis factor alpha in murine mycobacterial infection are dose dependent |
| Q36432177 | Immunoregulatory and antimicrobial effects of nitrogen oxides |
| Q54721991 | Impaired activation of Stat1 and c-Jun as a possible defect in macrophages of patients with active tuberculosis. |
| Q34168018 | Improved control of tuberculosis and activation of macrophages in mice lacking protein kinase R |
| Q38192925 | In search of a new paradigm for protective immunity to TB |
| Q41844976 | In vitro model of mycobacterial growth arrest using nitric oxide with limited air. |
| Q26741365 | In vitro mycobacterial growth inhibition assays: A tool for the assessment of protective immunity and evaluation of tuberculosis vaccine efficacy |
| Q39510966 | Increased antimycobacterial immunity in interleukin-10-deficient mice |
| Q44636469 | Increased interleukin-10 expression is not responsible for failure of T helper 1 immunity to resolve airborne Mycobacterium tuberculosis infection in mice |
| Q42479316 | Induced nitric oxide (NO) synthesis in heterologous nephrotoxic nephritis; effects of selective inhibition in neutrophil-dependent glomerulonephritis |
| Q42983436 | Inducible nitric oxide synthase gene (NOS2A) haplotypes and the outcome of hepatitis C virus infection |
| Q44064925 | Inducible nitric oxide synthase in the tuberculous human lung |
| Q37374566 | Inducible nitric oxide synthase: what difference does it make? |
| Q40566561 | Induction of iNOS expression and antimicrobial activity by interferon (IFN)-beta is distinct from IFN-gamma in Burkholderia pseudomallei-infected mouse macrophages |
| Q34006629 | Induction of inducible nitric oxide synthase-NO* by lipoarabinomannan of Mycobacterium tuberculosis is mediated by MEK1-ERK, MKK7-JNK, and NF-kappaB signaling pathways. |
| Q40545640 | Induction of nitric oxide release from the human alveolar epithelial cell line A549: an in vitro correlate of innate immune response to Mycobacterium tuberculosis |
| Q34828492 | Infection rate and tissue localization of murine IL-12p40-producing monocyte-derived CD103(+) lung dendritic cells during pulmonary tuberculosis |
| Q36847141 | Inhibition of IFN-γ-Induced Nitric Oxide Dependent Antimycobacterial Activity by miR-155 and C/EBPβ |
| Q27657451 | Inhibitors selective for mycobacterial versus human proteasomes |
| Q43266126 | Inhibitory effect of phytoglycoprotein (115 kDa) on the expression of TNF-alpha and interleukin-1beta via inhibition of MAP kinase in primary cultured mouse thymocytes |
| Q26751060 | Innate Immunity Holding the Flanks until Reinforced by Adaptive Immunity against Mycobacterium tuberculosis Infection |
| Q27000486 | Innate immune gene polymorphisms in tuberculosis |
| Q37950226 | Inside or outside the phagosome? The controversy of the intracellular localization of Mycobacterium tuberculosis. |
| Q36806048 | Insufficient Generation of Mycobactericidal Mediators and Inadequate Level of Phagosomal Maturation Are Related with Susceptibility to Virulent Mycobacterium tuberculosis Infection in Mouse Macrophages |
| Q40882568 | Interaction of antimycobacterial drugs with the anti-Mycobacterium avium complex effects of antimicrobial effectors, reactive oxygen intermediates, reactive nitrogen intermediates, and free fatty acids produced by macrophages |
| Q35563221 | Interactions between naïve and infected macrophages reduce Mycobacterium tuberculosis viability |
| Q36380807 | Interferon (IFN)-alpha activation of human blood mononuclear cells in vitro and in vivo for nitric oxide synthase (NOS) type 2 mRNA and protein expression: possible relationship of induced NOS2 to the anti-hepatitis C effects of IFN-alpha in vivo. |
| Q28478015 | Interferon gamma activated macrophages kill mycobacteria by nitric oxide induced apoptosis |
| Q28395075 | Interferon-alphabeta mediates partial control of early pulmonary Mycobacterium bovis bacillus Calmette-Guérin infection |
| Q40806985 | Interferon-gamma- and lipopolysaccharide-induced tumor necrosis factor-alpha is required for nitric oxide production: tumor necrosis factor-alpha and nitric oxide are independently involved in the killing of Mycobacterium microti in interferon-gamma |
| Q33596687 | Interferon-gamma-responsive nonhematopoietic cells regulate the immune response to Mycobacterium tuberculosis |
| Q90135468 | Interleukin 10 knock-down in bovine monocyte-derived macrophages has distinct effects during infection with two divergent strains of Mycobacterium bovis |
| Q37309538 | Interleukin-10 promotes Mycobacterium tuberculosis disease progression in CBA/J mice |
| Q61313267 | Interleukin-12p40 overexpression promotes interleukin-12p70 and interleukin-23 formation but does not affect bacille Calmette-Guérin and Mycobacterium tuberculosis clearance |
| Q40634545 | Intracellular expression of Mycobacterium tuberculosis-specific 10-kDa antigen down-regulates macrophage B7.1 expression and nitric oxide release. |
| Q44163367 | Investigation of chromosome 17 candidate genes in susceptibility to TB in a South African population |
| Q38055958 | In vitro infection of human cells with Mycobacterium tuberculosis. |
| Q92163260 | Iron Supplementation Therapy, A Friend and Foe of Mycobacterial Infections? |
| Q37778480 | Is Mycobacterium tuberculosis stressed out? A critical assessment of the genetic evidence |
| Q54976471 | Is Receptor-Interacting Protein Kinase 3 a Viable Therapeutic Target for Mycobacterium tuberculosis Infection? |
| Q56469515 | Is Total Serum Nitrite and Nitrate (NOx) Level in Dengue Patients a Potential Prognostic Marker of Dengue Hemorrhagic Fever? |
| Q34463493 | Is nitric oxide overproduction the target of choice for the management of septic shock? |
| Q38756763 | Lack of IL-1 Receptor-Associated Kinase-4 Leads to Defective Th1 Cell Responses and Renders Mice Susceptible to Mycobacterial Infection |
| Q45733743 | Lack of nitric oxide synthase type 2 (NOS2) results in reduced neuronal apoptosis and mortality following mouse hepatitis virus infection of the central nervous system |
| Q40065379 | Lactoferricin Peptides Increase Macrophages' Capacity To Kill Mycobacterium avium. |
| Q34297816 | Latent tuberculosis infection: myths, models, and molecular mechanisms |
| Q35211295 | Latent tuberculosis: mechanisms of host and bacillus that contribute to persistent infection |
| Q37421310 | Lazy, dynamic or minimally recrudescent? On the elusive nature and location of the mycobacterium responsible for latent tuberculosis |
| Q73002017 | Lethal Mycobacterium bovis Bacillus Calmette Guérin infection in nitric oxide synthase 2-deficient mice: cell-mediated immunity requires nitric oxide synthase 2 |
| Q36703585 | Life and death in the granuloma: immunopathology of tuberculosis |
| Q79243126 | Life on the inside for Mycobacterium tuberculosis |
| Q48165177 | Lipid droplet formation in Mycobacterium tuberculosis infected macrophages requires IFN-γ/HIF-1α signaling and supports host defense |
| Q28140459 | Lipoarabinomannan from Mycobacterium tuberculosis promotes macrophage survival by phosphorylating Bad through a phosphatidylinositol 3-kinase/Akt pathway |
| Q53908549 | Lung cell responses to M. tuberculosis in genetically susceptible and resistant mice following intratracheal challenge. |
| Q35605917 | M. tuberculosis persistence, latency, and drug tolerance |
| Q34280835 | Macrophage arginase-1 controls bacterial growth and pathology in hypoxic tuberculosis granulomas |
| Q38363796 | Macrophage defense mechanisms against intracellular bacteria. |
| Q35039679 | Macrophage immunoregulatory pathways in tuberculosis |
| Q38497801 | Macrophage takeover and the host-bacilli interplay during tuberculosis. |
| Q36959378 | Macrophage-mediated inflammatory response decreases mycobacterial survival in mouse MSCs by augmenting NO production |
| Q37856707 | Macrophages and control of granulomatous inflammation in tuberculosis |
| Q27319471 | Mechanism of inducible nitric oxide synthase exclusion from mycobacterial phagosomes |
| Q37118101 | Mechanisms and consequences of persistence of intracellular pathogens: leishmaniasis as an example. |
| Q30398195 | Metabolic Perspectives on Persistence |
| Q28590692 | Mice lacking inducible nitric oxide synthase demonstrate impaired killing of Porphyromonas gingivalis |
| Q37103066 | Microenvironments in tuberculous granulomas are delineated by distinct populations of macrophage subsets and expression of nitric oxide synthase and arginase isoforms |
| Q28362977 | Modulation of Mycobacterium bovis-specific responses of bovine peripheral blood mononuclear cells by 1,25-dihydroxyvitamin D(3) |
| Q80818732 | Modulation of immune responses in mice to recombinant antigens from PE and PPE families of proteins of Mycobacterium tuberculosis by the Ribi adjuvant |
| Q45829514 | Molecular Mechanisms Modulating the Phenotype of Macrophages and Microglia |
| Q36688480 | Molecular immunologic correlates of spontaneous latency in a rabbit model of pulmonary tuberculosis |
| Q35622988 | Molecular mechanisms of host-pathogen interaction: entry and survival of mycobacteria in macrophages. |
| Q91904779 | Mucosal-associated invariant T cells and disease |
| Q28540070 | Mycobacteria counteract a TLR-mediated nitrosative defense mechanism in a zebrafish infection model |
| Q37426403 | Mycobacteria inhibit nitric oxide synthase recruitment to phagosomes during macrophage infection |
| Q54520033 | Mycobacteria-induced granuloma necrosis depends on IRF-1. |
| Q28552338 | Mycobacterial Metabolic Syndrome: LprG and Rv1410 Regulate Triacylglyceride Levels, Growth Rate and Virulence in Mycobacterium tuberculosis |
| Q28083739 | Mycobacterial genes essential for the pathogen's survival in the host |
| Q35671416 | Mycobacterial glycolipids di-O-acylated trehalose and tri-O-acylated trehalose downregulate inducible nitric oxide synthase and nitric oxide production in macrophages |
| Q34426515 | Mycobacterium marinum causes a latent infection that can be reactivated by gamma irradiation in adult zebrafish |
| Q35598609 | Mycobacterium smegmatis RoxY is a repressor of oxyS and contributes to resistance to oxidative stress and bactericidal ubiquitin-derived peptides |
| Q39655566 | Mycobacterium tuberculosis CDC1551 is resistant to reactive nitrogen and oxygen intermediates in vitro |
| Q28486511 | Mycobacterium tuberculosis DosS is a redox sensor and DosT is a hypoxia sensor |
| Q93220808 | Mycobacterium tuberculosis Requires Regulation of ESX-5 Secretion for Virulence in Irgm1-Deficient Mice |
| Q91720786 | Mycobacterium tuberculosis Rv2700 Contributes to Cell Envelope Integrity and Virulence |
| Q28552573 | Mycobacterium tuberculosis Thioredoxin Reductase Is Essential for Thiol Redox Homeostasis but Plays a Minor Role in Antioxidant Defense |
| Q52722200 | Mycobacterium tuberculosis Transfer RNA Induces IL-12p70 via Synergistic Activation of Pattern Recognition Receptors within a Cell Network. |
| Q89997913 | Mycobacterium tuberculosis WhiB3 maintains redox homeostasis and survival in response to reactive oxygen and nitrogen species |
| Q36223232 | Mycobacterium tuberculosis WhiB4 regulates oxidative stress response to modulate survival and dissemination in vivo. |
| Q36938592 | Mycobacterium tuberculosis and the environment within the phagosome |
| Q35216595 | Mycobacterium tuberculosis and the intimate discourse of a chronic infection |
| Q64964405 | Mycobacterium tuberculosis carrying a rifampicin drug resistance mutation reprograms macrophage metabolism through cell wall lipid changes. |
| Q28486947 | Mycobacterium tuberculosis conserved hypothetical protein rRv2626c modulates macrophage effector functions |
| Q28486777 | Mycobacterium tuberculosis expresses methionine sulphoxide reductases A and B that protect from killing by nitrite and hypochlorite |
| Q34945420 | Mycobacterium tuberculosis growth at the cavity surface: a microenvironment with failed immunity |
| Q41374063 | Mycobacterium tuberculosis has diminished capacity to counteract redox stress induced by elevated levels of endogenous superoxide. |
| Q27633806 | Mycobacterium tuberculosis hemoglobin N displays a protein tunnel suited for O2 diffusion to the heme |
| Q45000171 | Mycobacterium tuberculosis induces high production of nitric oxide in coordination with production of tumour necrosis factor-alpha in patients with fresh active tuberculosis but not in MDR tuberculosis |
| Q34213787 | Mycobacterium tuberculosis pathogenesis and molecular determinants of virulence |
| Q33982151 | Mycobacterium tuberculosis persistence mutants identified by screening in isoniazid-treated mice |
| Q28486412 | Mycobacterium tuberculosis prcBA genes encode a gated proteasome with broad oligopeptide specificity |
| Q34747029 | Mycobacterium tuberculosis protein kinase K confers survival advantage during early infection in mice and regulates growth in culture and during persistent infection: implications for immune modulation |
| Q36506132 | Mycobacterium tuberculosis requires phosphate-responsive gene regulation to resist host immunity. |
| Q38268279 | Mycobacterium tuberculosis response to stress from reactive oxygen and nitrogen species |
| Q34089860 | Mycobacterium tuberculosis wears what it eats |
| Q29619735 | Mycobacterium tuberculosis: here today, and here tomorrow |
| Q38686660 | Mycobacterium tuberculosis: what is the role of PPE2 during infection? |
| Q91321395 | Mycoplasma bovis delay in apoptosis of macrophages is accompanied by increased expression of anti-apoptotic genes, reduced cytochrome C translocation and inhibition of DNA fragmentation |
| Q61755441 | Mycothiol-dependent mycobacterial response to oxidative stress |
| Q90674170 | Myeloid HIF-1α regulates pulmonary inflammation during experimental Mycobacterium tuberculosis infection |
| Q41969521 | N,C-Capped dipeptides with selectivity for mycobacterial proteasome over human proteasomes: role of S3 and S1 binding pockets |
| Q38937950 | NOD-2 and TLR-4 Signaling Reinforces the Efficacy of Dendritic Cells and Reduces the Dose of TB Drugs against Mycobacterium tuberculosis. |
| Q40087530 | NOS2-deficient mice with hypoxic necrotizing lung lesions predict outcomes of tuberculosis chemotherapy in humans |
| Q44558306 | NOS2-derived nitric oxide regulates the size, quantity and quality of granuloma formation in Mycobacterium avium-infected mice without affecting bacterial loads |
| Q39304314 | NOS2A promoter (CCTTT)n association with TB lacks independent functional correlation amongst Indians |
| Q33896845 | NOS2A, TLR4, and IFNGR1 interactions influence pulmonary tuberculosis susceptibility in African-Americans |
| Q34460946 | Natural transmission of Plasmodium berghei exacerbates chronic tuberculosis in an experimental co-infection model |
| Q40868823 | Naturally produced opsonizing antibodies restrict the survival of Mycobacterium tuberculosis in human macrophages by augmenting phagosome maturation |
| Q48138531 | Necroptotic signaling is primed in Mycobacterium tuberculosis-infected macrophages, but its pathophysiological consequence in disease is restricted |
| Q42908536 | Neuroinflammation, Oxidative Stress and the Pathogenesis of Parkinson's Disease |
| Q28388477 | New insights into TB physiology suggest untapped therapeutic opportunities |
| Q35095367 | New targets and inhibitors of mycobacterial sulfur metabolism. |
| Q90468452 | Nitric Oxide Engages an Anti-inflammatory Feedback Loop Mediated by Peroxiredoxin 5 in Phagocytes |
| Q40115065 | Nitric Oxide Modulates Macrophage Responses to Mycobacterium tuberculosis Infection through Activation of HIF-1α and Repression of NF-κB. |
| Q33734476 | Nitric oxide and infectious diseases |
| Q29617591 | Nitric oxide and the immune response |
| Q27485884 | Nitric oxide and virus infection |
| Q34941147 | Nitric oxide as an inflammatory mediator in autoimmune MRL-lpr/lpr mice |
| Q37040409 | Nitric oxide controls the immunopathology of tuberculosis by inhibiting NLRP3 inflammasome-dependent processing of IL-1β. |
| Q37400186 | Nitric oxide in dengue and dengue haemorrhagic fever: necessity or nuisance? |
| Q77802828 | Nitric oxide in the failing myocardium |
| Q34984498 | Nitric oxide inhibits exocytosis of cytolytic granules from lymphokine-activated killer cells |
| Q36875493 | Nitric oxide inhibits the accumulation of CD4+CD44hiTbet+CD69lo T cells in mycobacterial infection |
| Q48022256 | Nitric oxide participation in granulomatous response induced by Paracoccidioides brasiliensis infection in mice |
| Q34932787 | Nitric oxide protects bacteria from aminoglycosides by blocking the energy-dependent phases of drug uptake |
| Q28486473 | Nitric oxide scavenging and detoxification by the Mycobacterium tuberculosis haemoglobin, HbN in Escherichia coli |
| Q35061791 | Nitric oxide synthase activity has limited influence on the control of Coccidioides infection in mice |
| Q35558464 | Nitric oxide, inflammation and acute burn injury |
| Q48379508 | Nitric oxide: from a mysterious labile factor to the molecule of the Nobel Prize. Recent progress in nitric oxide research |
| Q37318269 | Nitrite produced by Mycobacterium tuberculosis in human macrophages in physiologic oxygen impacts bacterial ATP consumption and gene expression |
| Q38253107 | Nitrogen metabolism in Mycobacterium tuberculosis physiology and virulence |
| Q34381833 | Nitrosylation. the prototypic redox-based signaling mechanism. |
| Q58846273 | No evidence for association of the inducible nitric oxide synthase promoter polymorphism with Trypanosoma cruzi infection |
| Q36342789 | Nonsteroidal anti-inflammatory drug sensitizes Mycobacterium tuberculosis to endogenous and exogenous antimicrobials |
| Q37101494 | Novel Cephalosporins Selectively Active on Nonreplicating Mycobacterium tuberculosis |
| Q27757495 | Novel non-heme iron center of nitrile hydratase with a claw setting of oxygen atoms |
| Q47136699 | Nucleotide-Binding Oligomerization Domain 2 Contributes to Limiting Growth of Mycobacterium abscessus in the Lung of Mice by Regulating Cytokines and Nitric Oxide Production |
| Q43985483 | On the killing of mycobacteria by macrophages |
| Q36580383 | One Episode of Self-Resolving Plasmodium yoelii Infection Transiently Exacerbates Chronic Mycobacterium tuberculosis Infection |
| Q38672958 | Oxidative Phosphorylation as a Target Space for Tuberculosis: Success, Caution, and Future Directions |
| Q39567733 | Oxidative stress response and characterization of the oxyR-ahpC and furA-katG loci in Mycobacterium marinum. |
| Q34543665 | Oxygen binding and NO scavenging properties of truncated hemoglobin, HbN, of Mycobacterium smegmatis |
| Q24654913 | PA-824 kills nonreplicating Mycobacterium tuberculosis by intracellular NO release |
| Q38085418 | PPE2 protein of Mycobacterium tuberculosis may inhibit nitric oxide in activated macrophages |
| Q35150831 | Patients with tuberculosis disease have Mycobacterium tuberculosis-specific CD8 T cells with a pro-apoptotic phenotype and impaired proliferative capacity, which is not restored following treatment |
| Q40548422 | Peroxiredoxin 1 Contributes to Host Defenses against Mycobacterium tuberculosis. |
| Q35889600 | Persistent bacterial infections: the interface of the pathogen and the host immune system |
| Q37368468 | Perspectives series: host/pathogen interactions. Mechanisms of nitric oxide-related antimicrobial activity |
| Q37945715 | Pharmacogenetics of the lipodystrophy syndrome associated with HIV infection and combination antiretroviral therapy. |
| Q33793673 | Pharmacological modulation of nitric oxide synthesis by mechanism-based inactivators and related inhibitors |
| Q45274479 | Phenotype of mice and macrophages deficient in both phagocyte oxidase and inducible nitric oxide synthase. |
| Q36914816 | Phthiocerol dimycocerosate transport is required for resisting interferon-gamma-independent immunity |
| Q38484210 | Phylogenomics of Mycobacterium Nitrate Reductase Operon |
| Q36163097 | Polyclonal mucosa-associated invariant T cells have unique innate functions in bacterial infection |
| Q35208353 | Preexisting helminth infection induces inhibition of innate pulmonary anti-tuberculosis defense by engaging the IL-4 receptor pathway |
| Q58553806 | Presence of Infected Gr-1CD11bCD11c Monocytic Myeloid Derived Suppressor Cells Subverts T Cell Response and Is Associated With Impaired Dendritic Cell Function in -Infected Mice |
| Q37282737 | Progress and new directions in genetics of tuberculosis: an NHLBI working group report |
| Q39076238 | Prokaryotic expression and functional analysis of the Mb1514 gene in Mycobacterium bovis |
| Q37502693 | Prokaryotic ubiquitin-like protein (Pup), proteasomes and pathogenesis |
| Q28487570 | Proteasomal control of cytokinin synthesis protects Mycobacterium tuberculosis against nitric oxide |
| Q37204436 | Protection of Mycobacterium tuberculosis from reactive oxygen species conferred by the mel2 locus impacts persistence and dissemination |
| Q38247209 | Protective immune responses to fungal infections |
| Q37033735 | Protective role of membrane tumour necrosis factor in the host's resistance to mycobacterial infection |
| Q33751428 | Protective role of nitric oxide in Staphylococcus aureus infection in mice |
| Q91966785 | Protein-protein interaction of Rv0148 with Htdy and its predicted role towards drug resistance in Mycobacterium tuberculosis |
| Q38321484 | Pulmonary Mycobacterium tuberculosis infection in leptin-deficient ob/ob mice |
| Q36404225 | Rapid interferon gamma-dependent clearance of influenza A virus and protection from consolidating pneumonitis in nitric oxide synthase 2-deficient mice |
| Q43245570 | Rapid, Semiquantitative Assay To Discriminate among Compounds with Activity against Replicating or Nonreplicating Mycobacterium tuberculosis. |
| Q37190166 | Reaction of Mycobacterium tuberculosis cytochrome P450 enzymes with nitric oxide |
| Q34001719 | Reactivation of latent tuberculosis: variations on the Cornell murine model |
| Q33840580 | Reactive nitrogen intermediates and the pathogenesis of Salmonella and mycobacteria |
| Q39664494 | Reactive nitrogen intermediates have a bacteriostatic effect on Mycobacterium tuberculosis in vitro |
| Q24630289 | Reactive oxygen and nitrogen intermediates in the relationship between mammalian hosts and microbial pathogens |
| Q33840513 | Reactive oxygen and reactive nitrogen intermediates in innate and specific immunity |
| Q34851055 | Recombinant gamma interferon stimulates signal transduction and gene expression in alveolar macrophages in vitro and in tuberculosis patients |
| Q27012879 | Redox homeostasis in mycobacteria: the key to tuberculosis control? |
| Q35356550 | Reduced oxidative and nitrosative damage in murine experimental colitis in the absence of inducible nitric oxide synthase |
| Q40136119 | Reduced susceptibility of clinical strains of Mycobacterium tuberculosis to reactive nitrogen species promotes survival in activated macrophages |
| Q28539327 | Reengineering redox sensitive GFP to measure mycothiol redox potential of Mycobacterium tuberculosis during infection |
| Q58461876 | Regulation of granuloma fibrosis by nitric oxide during Mycobacterium avium experimental infection |
| Q36040945 | Regulation of innate immunity by NADPH oxidase |
| Q60300625 | Regulation of mycobacterial infection by macrophage Gch1 and tetrahydrobiopterin |
| Q35441389 | Regulation of neutrophils by interferon-γ limits lung inflammation during tuberculosis infection |
| Q28487527 | Regulation of the Mycobacterium tuberculosis hypoxic response gene encoding α-crystallin |
| Q34445693 | Regulation of the ahpC gene encoding alkyl hydroperoxide reductase in Mycobacterium smegmatis |
| Q50319373 | Reinforcing the Functionality of Mononuclear Phagocyte System to Control Tuberculosis |
| Q36669873 | Relationship of bovine NOS2 gene polymorphisms to the risk of bovine tuberculosis in Holstein cattle. |
| Q33943840 | Replication of Yersinia pestis in interferon gamma-activated macrophages requires ripA, a gene encoded in the pigmentation locus |
| Q36369581 | Reprogramming of the macrophage transcriptome in response to interferon-gamma and Mycobacterium tuberculosis: signaling roles of nitric oxide synthase-2 and phagocyte oxidase |
| Q28487034 | Response to reactive nitrogen intermediates in Mycobacterium tuberculosis: induction of the 16-kilodalton alpha-crystallin homolog by exposure to nitric oxide donors |
| Q38003929 | Revisiting the role of the granuloma in tuberculosis |
| Q62488588 | Rifampicin and dexamethasone have similar effects on macrophage phagocytosis of zymosan, but differ in their effects on nitrite and TNF-α production |
| Q42237169 | Rifampin augments cytokine-induced nitric oxide production in human alveolar epithelial cells |
| Q35627704 | Role for NOD2 in Mycobacterium tuberculosis-induced iNOS expression and NO production in human macrophages |
| Q41946149 | Role for nucleotide excision repair in virulence of Mycobacterium tuberculosis |
| Q28486437 | Role of Mycobacterium tuberculosis copper-zinc superoxide dismutase |
| Q43126200 | Role of Pre-A motif in nitric oxide scavenging by truncated hemoglobin, HbN, of Mycobacterium tuberculosis. |
| Q34191797 | Role of free radicals in viral pathogenesis and mutation |
| Q33600697 | Role of inducible nitric oxide synthase in resistance to Mycobacterium leprae in mice |
| Q34418998 | Role of nitric oxide in inflammation |
| Q34714207 | Role of the NF-kappaB signaling pathway and kappaB cis-regulatory elements on the IRF-1 and iNOS promoter regions in mycobacterial lipoarabinomannan induction of nitric oxide |
| Q37099497 | Role of the dosR-dosS two-component regulatory system in Mycobacterium tuberculosis virulence in three animal models. |
| Q24546207 | S-Nitrosogluthathione reductase activity of amphioxus ADH3: insights into the nitric oxide metabolism |
| Q33722881 | S-nitroso proteome of Mycobacterium tuberculosis: Enzymes of intermediary metabolism and antioxidant defense |
| Q35119656 | S-nitrosylation in health and disease |
| Q52728434 | S-nitrosylation of NADPH oxidase regulates cell death in plant immunity. |
| Q57471957 | S-nitrosylation of the zinc finger protein SRG1 regulates plant immunity |
| Q40623428 | STAT3 Represses Nitric Oxide Synthesis in Human Macrophages upon Mycobacterium tuberculosis Infection |
| Q90521129 | Salmonella Persist in Activated Macrophages in T Cell-Sparse Granulomas but Are Contained by Surrounding CXCR3 Ligand-Positioned Th1 Cells |
| Q28505858 | Serine protease activity contributes to control of Mycobacterium tuberculosis in hypoxic lung granulomas in mice |
| Q34009146 | Silencing of oxidative stress response in Mycobacterium tuberculosis: expression patterns of ahpC in virulent and avirulent strains and effect of ahpC inactivation |
| Q64097469 | Spatial and temporal localization of immune transcripts defines hallmarks and diversity in the tuberculosis granuloma |
| Q58889002 | Species-Specific Transcriptional Regulation of Genes Involved in Nitric Oxide Production and Arginine Metabolism in Macrophages |
| Q27694770 | Spotlights on immunological effects of reactive nitrogen species: When inflammation says nitric oxide |
| Q39437320 | Striking the right immunological balance prevents progression of tuberculosis |
| Q47259350 | Structure of a Wbl protein and implications for NO sensing by M. tuberculosis. |
| Q45066836 | Study on myeloperoxidase role in antituberculous defense in the context of cytokine activation |
| Q45952650 | Suppression of IFNgamma+mycobacterial lipoarabinomannan-induced NO by IL-4 is due to decreased IRF-1 expression. |
| Q28397253 | Suppression of the NF-κB pathway by diesel exhaust particles impairs human antimycobacterial immunity |
| Q47109680 | Suppressor of Cytokine Signaling 3 in Macrophages Prevents Exacerbated Interleukin-6-Dependent Arginase-1 Activity and Early Permissiveness to Experimental Tuberculosis. |
| Q51655159 | Surfactant protein A enhances Mycobacterium avium ingestion but not killing by rat macrophages. |
| Q33842618 | Surfactant protein A suppresses reactive nitrogen intermediates by alveolar macrophages in response to Mycobacterium tuberculosis |
| Q33876178 | Survival of Mycobacterium avium and Mycobacterium tuberculosis in acidified vacuoles of murine macrophages |
| Q51984727 | Susceptibility and resistance to monocytic ehrlichiosis in the mouse. |
| Q53854589 | Susceptibility of brushtail possums (Trichosurus vulpecula) infected with Mycobacterium bovis is associated with a transient macrophage activation profile. |
| Q98224728 | Susceptibility to Intracellular Infections: Contributions of TNF to Immune Defense |
| Q36241272 | Sustained generation of nitric oxide and control of mycobacterial infection requires argininosuccinate synthase 1. |
| Q38742184 | T Cell-Derived IL-10 Impairs Host Resistance to Mycobacterium tuberculosis Infection |
| Q33536568 | T cell mediated immunity to Mycobacterium tuberculosis |
| Q45948289 | T-cell release of granulysin contributes to host defense in leprosy. |
| Q28083600 | TB drug development: immunology at the table |
| Q38166990 | TB or not TB: that is no longer the question |
| Q37435926 | TB vaccines: current status and future perspectives |
| Q36666348 | TGF beta 1 and TNF alpha potentiate nitric oxide production in astrocyte cultures by recruiting distinct subpopulations of cells to express NOS-2. |
| Q40178443 | TLR2 but not TLR4 signalling is critically involved in the inhibition of IFN-gamma-induced killing of mycobacteria by murine macrophages |
| Q36403076 | TLR9 regulates Th1 responses and cooperates with TLR2 in mediating optimal resistance to Mycobacterium tuberculosis. |
| Q41816750 | TNF dually mediates resistance and susceptibility to mycobacteria via mitochondrial reactive oxygen species |
| Q55287141 | TNF-α blockade impairs in vitro tuberculous granuloma formation and down modulate Th1, Th17 and Treg cytokines. |
| Q37891774 | Taking Out TB-Lysosomal Trafficking and Mycobactericidal Ubiquitin-Derived Peptides |
| Q39149038 | Targeting Phenotypically Tolerant Mycobacterium tuberculosis |
| Q24644997 | Targeting of the GTPase Irgm1 to the phagosomal membrane via PtdIns(3,4)P(2) and PtdIns(3,4,5)P(3) promotes immunity to mycobacteria |
| Q52692190 | Targeting the Proteostasis Network for Mycobacterial Drug Discovery. |
| Q26774207 | Th1 and Th17 Cells in Tuberculosis: Protection, Pathology, and Biomarkers |
| Q49900955 | Th1 cytokines, true functional signatures for protective immunity against TB? |
| Q38314435 | The BER necessities: the repair of DNA damage in human-adapted bacterial pathogens. |
| Q39727290 | The CFP-10/ESAT-6 complex of Mycobacterium tuberculosis potentiates the activation of murine macrophages involvement of IFN-gamma signaling |
| Q43082287 | The IL-13/IL-4Rα axis is involved in tuberculosis-associated pathology |
| Q37594360 | The Minimal Unit of Infection: Mycobacterium tuberculosis in the Macrophage |
| Q35628763 | The Mycobacterium marinum mel2 locus displays similarity to bacterial bioluminescence systems and plays a role in defense against reactive oxygen and nitrogen species |
| Q42600002 | The Mycobacterium tuberculosis SecA2 system subverts phagosome maturation to promote growth in macrophages. |
| Q33658714 | The Mycobacterium tuberculosis proteasome active site threonine is essential for persistence yet dispensable for replication and resistance to nitric oxide |
| Q37578057 | The Mycobacterium tuberculosis proteasome: more than just a barrel-shaped protease |
| Q54286145 | The Mycobacterium tuberculosis recombinant LprN protein of mce4 operon induces Th-1 type response deleterious to protection in mice. |
| Q27702517 | The N-terminal pre-A region of Mycobacterium tuberculosis 2/2HbN promotes NO-dioxygenase activity |
| Q26825089 | The Pup-Proteasome System of Mycobacteria |
| Q27490787 | The Role of Nitric Oxide in Mycobacterial Infections |
| Q34026690 | The SPRY domain-containing SOCS box protein SPSB2 targets iNOS for proteasomal degradation |
| Q34888988 | The Sculpting of the Mycobacterium tuberculosis Genome by Host Cell-Derived Pressures |
| Q28487596 | The SecA2 secretion factor of Mycobacterium tuberculosis promotes growth in macrophages and inhibits the host immune response |
| Q30402360 | The Tyrosine Kinase Inhibitor Gefitinib Restricts Mycobacterium tuberculosis Growth through Increased Lysosomal Biogenesis and Modulation of Cytokine Signaling. |
| Q39613066 | The capsule supports survival but not traversal of Escherichia coli K1 across the blood-brain barrier. |
| Q26744038 | The emerging role of gasotransmitters in the pathogenesis of tuberculosis |
| Q34595822 | The endothelin system has a significant role in the pathogenesis and progression of Mycobacterium tuberculosis infection. |
| Q38872142 | The fibroblast growth factor-2 arrests Mycobacterium avium sp. paratuberculosis growth and immunomodulates host response in macrophages |
| Q55653568 | The functional interplay of low molecular weight thiols in Mycobacterium tuberculosis. |
| Q41727902 | The host immune response to tuberculosis |
| Q35676581 | The immunological aspects of latency in tuberculosis |
| Q33777367 | The immunology of tuberculosis: from bench to bedside |
| Q34009836 | The inducible nitric oxide synthase locus confers protection against aerogenic challenge of both clinical and laboratory strains of Mycobacterium tuberculosis in mice |
| Q37123814 | The intracellular environment of human macrophages that produce nitric oxide promotes growth of mycobacteria. |
| Q36838527 | The iron export protein ferroportin 1 is differentially expressed in mouse macrophage populations and is present in the mycobacterial-containing phagosome. |
| Q37419579 | The macrophage marches on its phagosome: dynamic assays of phagosome function. |
| Q34266438 | The many faces of host responses to tuberculosis |
| Q28487623 | The multifunctional histone-like protein Lsr2 protects mycobacteria against reactive oxygen intermediates |
| Q36075177 | The pathogenesis of tuberculosis: the first one hundred (and twenty-three) years |
| Q36376221 | The relative importance of T cell subsets in immunity and immunopathology of airborne Mycobacterium tuberculosis infection in mice |
| Q37859621 | The role of IL-10 in immune regulation during M. tuberculosis infection |
| Q37374958 | The role of cytokines in the initiation, expansion, and control of cellular immunity to tuberculosis |
| Q34265039 | The role of gamma interferon in antimicrobial immunity |
| Q44891712 | The role of nitric oxide in lung innate immunity: modulation by surfactant protein-A. |
| Q47286732 | The role of nitric oxide in metabolic regulation of Dendritic cell immune function |
| Q26863204 | The role of pro-resolution lipid mediators in infectious disease |
| Q41965764 | The toll-like receptor 2/6 ligand MALP-2 reduces the viability of Mycobacterium tuberculosis in murine macrophages |
| Q58746346 | Tolerating the Unwelcome Guest; How the Host Withstands Persistent |
| Q35609316 | Toll-like receptor 2-dependent extracellular signal-regulated kinase signaling in Mycobacterium tuberculosis-infected macrophages drives anti-inflammatory responses and inhibits Th1 polarization of responding T cells |
| Q40104128 | Toll-like receptor genes are differentially expressed at the sites of infection during the progression of Johne's disease in outbred sheep. |
| Q34049969 | Toll-like receptors: molecular mechanisms of the mammalian immune response |
| Q37228738 | Toll-like receptors: their roles in bacterial recognition and respiratory infections |
| Q96435430 | Topologically correct synthetic reconstruction of pathogen social behavior found during Yersinia growth in deep tissue sites |
| Q35117081 | Trans-species communication in the Mycobacterium tuberculosis-infected macrophage |
| Q37248992 | Transcriptional characterization of the antioxidant response of Mycobacterium tuberculosis in vivo and during adaptation to hypoxia in vitro |
| Q54224374 | Transcriptional landscape of Mycobacterium tuberculosis infection in macrophages. |
| Q41570545 | Transcriptome changes upon in vitro challenge with Mycobacterium bovis in monocyte-derived macrophages from bovine tuberculosis-infected and healthy cows |
| Q28593510 | Transient loss of resistance to pulmonary tuberculosis in p47(phox-/-) mice |
| Q27658975 | Triazaspirodimethoxybenzoyls as Selective Inhibitors of Mycobacterial Lipoamide Dehydrogenase, |
| Q36970544 | Triggering through NOD-2 Differentiates Bone Marrow Precursors to Dendritic Cells with Potent Bactericidal activity |
| Q28486863 | Truncated hemoglobin HbN protects Mycobacterium bovis from nitric oxide |
| Q35988766 | Tuberculosis - metabolism and respiration in the absence of growth |
| Q47720001 | Tuberculosis Infectiousness and Host Susceptibility |
| Q37270954 | Tuberculosis Susceptibility and Vaccine Protection Are Independently Controlled by Host Genotype |
| Q21131403 | Tuberculosis and HIV co-infection |
| Q34974987 | Tuberculosis chemotherapy: the influence of bacillary stress and damage response pathways on drug efficacy |
| Q28201426 | Tuberculosis: latency and reactivation |
| Q35094378 | Tuberculosis: new aspects of an old disease. |
| Q45929497 | Tumor Necrosis Factor-Alpha Targeting Can Protect against Arthritis with Low Sensitization to Infection. |
| Q33315753 | Tumor necrosis factor blockade in chronic murine tuberculosis enhances granulomatous inflammation and disorganizes granulomas in the lungs |
| Q44248030 | Type 1 interferon (IFNalpha/beta) and type 2 nitric oxide synthase regulate the innate immune response to a protozoan parasite |
| Q37465000 | Type I IFN Inhibits Alternative Macrophage Activation during Mycobacterium tuberculosis Infection and Leads to Enhanced Protection in the Absence of IFN-γ Signaling |
| Q34222028 | Type I IFN induces IL-10 production in an IL-27-independent manner and blocks responsiveness to IFN-γ for production of IL-12 and bacterial killing in Mycobacterium tuberculosis-infected macrophages |
| Q35851626 | Understanding latent tuberculosis: a moving target |
| Q39010964 | Violent suicidal behaviour in bipolar disorder is associated with nitric oxide synthase 3 gene polymorphism. |
| Q35097591 | Virulence factor SenX3 is the oxygen-controlled replication switch of Mycobacterium tuberculosis |
| Q36371162 | Virulent but not avirulent Mycobacterium tuberculosis can evade the growth inhibitory action of a T helper 1-dependent, nitric oxide Synthase 2-independent defense in mice |
| Q34442443 | What is the role of nitric oxide in murine and human host defense against tuberculosis?Current knowledge |
| Q36044574 | Widespread bronchogenic dissemination makes DBA/2 mice more susceptible than C57BL/6 mice to experimental aerosol infection with Mycobacterium tuberculosis |
| Q49956938 | c-Abl-TWIST1 Epigenetically Dysregulate Inflammatory Responses during Mycobacterial Infection by Co-Regulating Bone Morphogenesis Protein and miR27a |
| Q36741352 | microRNA-146a promotes mycobacterial survival in macrophages through suppressing nitric oxide production |
| Q30720627 | noxR3, a novel gene from Mycobacterium tuberculosis, protects Salmonella typhimurium from nitrosative and oxidative stress. |
| Q35709631 | p47 GTPases: regulators of immunity to intracellular pathogens |
Search more.